Ectopic hormone secretion syndrome associated with neoplasia

Summary

Ectopic hormone secretion syndrome associated with neoplasia (MONDO:0045072) is a disease. A subtype of neoplastic syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	ectopic hormone secretion syndrome associated with neoplasia
Mondo ID	MONDO:0045072
NCIT	C4065
UMLS	C0851689
MedGen	208863
Is cancer (heuristic)	no

Also known as: ectopic hormone secretion syndrome associated with neoplasia · neoplasm associated ectopic hormone secretion syndrome

Disease family

This is a subtype of neoplastic syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › syndromic disease › neoplastic syndrome › ectopic hormone secretion syndrome associated with neoplasia

Related subtypes (10): Carney triad, hereditary neoplastic syndrome, Meigs syndrome, growing teratoma syndrome, autoimmune lymphoproliferative syndrome, myelodysplastic syndrome, Zollinger-Ellison syndrome, Pancoast syndrome, ectopic ACTH secretion syndrome, tumor lysis syndrome

Subtypes (1): inappropriate ADH syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.